COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 206.2 | 8 | 0127-0421 | 609.03 | 421.87 | 466 | 80.91 | 0.894 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 636.1 | 8 | 0128-0421 | 828.47 | 421.78 | 413 | 76.67 | 0.883 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 193.0 | 8 | 0129-0422 | 193.23 | 422.30 | 385 | 71.60 | 0.944 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 201.2 | 8 | 0130-0421 | 261.09 | 421.26 | 380 | 73.60 | 0.882 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 553.9 | 8 | 0131-0421 | 928.44 | 421.32 | 423 | 79.01 | 0.851 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 163.1 | 8 | 0132-0431 | 84.88 | 431.14 | 373 | 73.26 | 0.873 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 672.4 | 8 | 0133-0429 | 901.87 | 428.91 | 391 | 76.18 | 0.847 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 206.9 | 8 | 0134-0434 | 390.13 | 434.87 | 380 | 73.01 | 0.896 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 275.1 | 8 | 0135-0439 | 573.78 | 438.71 | 432 | 77.01 | 0.915 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 231.2 | 8 | 0136-0443 | 677.38 | 443.35 | 419 | 75.01 | 0.936 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 509.7 | 8 | 0137-0443 | 127.46 | 443.00 | 401 | 75.50 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 173.4 | 8 | 0138-0443 | 298.30 | 442.84 | 387 | 74.67 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.9 | 8 | 0139-0445 | 250.82 | 443.39 | 360 | 72.91 | 0.851 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 167.0 | 8 | 0140-0451 | 21.71 | 450.93 | 367 | 71.84 | 0.894 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 200.4 | 8 | 0141-0451 | 57.31 | 451.96 | 366 | 71.60 | 0.897 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 313.7 | 8 | 0142-0456 | 266.57 | 457.00 | 385 | 74.57 | 0.870 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 190.4 | 8 | 0143-0456 | 757.54 | 456.78 | 401 | 73.84 | 0.924 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 458.1 | 8 | 0144-0465 | 695.31 | 464.74 | 333 | 66.77 | 0.939 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 188.7 | 8 | 0145-0475 | 624.02 | 474.88 | 775 | 109.64 | 0.810 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 221.9 | 8 | 0146-0472 | 545.34 | 472.55 | 230 | 55.94 | 0.924 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.7 | 8 | 0147-0479 | 826.55 | 478.30 | 624 | 92.33 | 0.920 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.0 | 8 | 0148-0480 | 103.11 | 480.20 | 386 | 73.60 | 0.895 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.0 | 8 | 0149-0482 | 470.82 | 480.83 | 343 | 70.91 | 0.857 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 209.0 | 8 | 0150-0483 | 257.38 | 482.81 | 373 | 70.77 | 0.936 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1874.7 | 8 | 0151-0487 | 382.59 | 487.61 | 326 | 65.94 | 0.942 |